149 related articles for article (PubMed ID: 4651207)
1. Cardiac and peripheral vascular effects of pralidoxime chloride.
Barnes GE; Bishop VS; Kardon MB
Eur J Pharmacol; 1972 Nov; 20(2):188-94. PubMed ID: 4651207
[No Abstract] [Full Text] [Related]
2. Cardiovascular effects of dopamine in the anaesthetized dog.
Sampson RG; Scroop GC; Louis WJ
Clin Exp Pharmacol Physiol; 1974; 1(1):3-12. PubMed ID: 4457265
[No Abstract] [Full Text] [Related]
3. [Mechanism of the antihypertensive action of propranolol].
Magnani B; Ambrosioni E; Branzi A; Maresta A; Picchio F; Russo F; Sanguinetti M
Minerva Cardioangiol; 1973 Apr; 21(4):284-97. PubMed ID: 4710125
[No Abstract] [Full Text] [Related]
4. Neurogenic maintenance of peripheral resistance in borderline hypertension.
Julius S; Esler M; Randall OS; Ellis C
Acta Physiol Lat Am; 1974; 24(5):425-31. PubMed ID: 4467668
[No Abstract] [Full Text] [Related]
5. [The effects of inotropic substances on the heart dynamics and peripheral blood circulation].
Schüren KP; Buschmann J; Meyer V; Schröder R
Verh Dtsch Ges Kreislaufforsch; 1968; 34():206-13. PubMed ID: 4899541
[No Abstract] [Full Text] [Related]
6. Glucagon: its mechanism of action on the coronary circulation in the conscious dog.
Terry B; White FC; Bloor CM
Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531
[No Abstract] [Full Text] [Related]
7. Hemodynamic studies on hypertension. II. Effects of isoproterenol, propranolol, noradrenaline and phentolamine on the hemodynamics in essential hypertension.
Tsuchiya M
Jpn Circ J; 1972 Mar; 36(3):275-88. PubMed ID: 5068095
[No Abstract] [Full Text] [Related]
8. Influence of phentolamine on the cardiovascular effects of dopamine in experimental cardiogenic shock.
Bagwell EE; Daniell HB; Freeman BF
Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):197-203. PubMed ID: 4852444
[No Abstract] [Full Text] [Related]
9. Cardiac actions of oxprenolol as studied in dog heart-lung preparations.
Takeda K; Iizuka H; Imai S
Arzneimittelforschung; 1973 Oct; 23(10):1446-50. PubMed ID: 4149692
[No Abstract] [Full Text] [Related]
10. [Changes in cardiac output and total peripheral resistance under the influence of anti-adrenergic substances].
Kinin IE; Iuzhakov SO
Farmakol Toksikol; 1973; 36(2):238-42. PubMed ID: 4791602
[No Abstract] [Full Text] [Related]
11. Haemodynamic response to exercise after combined sympathetic and parasympathetic blockade of the heart.
Nordenfelt I
Cardiovasc Res; 1971 Apr; 5(2):215-22. PubMed ID: 5579525
[No Abstract] [Full Text] [Related]
12. Hemodynamic effects of a moderate increase of the plasma vasopressin level in conscious dogs.
Szczepańska-Sadowska E
Pflugers Arch; 1973; 338(4):313-22. PubMed ID: 4734844
[No Abstract] [Full Text] [Related]
13. Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine.
Brunner H; Hedwall PR; Meier M
Br J Pharmacol Chemother; 1967 May; 30(1):123-33. PubMed ID: 6039968
[No Abstract] [Full Text] [Related]
14. Actions of bretylium tosylate on the cardiovascular system of the dog.
Richmond DR; Angus JA; Goodman AH; Cobbin LB
Cardiovasc Res; 1973 Jan; 7(1):47-54. PubMed ID: 4694956
[No Abstract] [Full Text] [Related]
15. Hemodynamic responses to beta-adrenergic blockade in dogs.
Shen Y; Quiroz AC; Burch GE; DePasquale NP
Am Heart J; 1967 May; 73(5):669-73. PubMed ID: 4225818
[No Abstract] [Full Text] [Related]
16. Cardiovascular effects of 2-pyridine aldoxime methylchloride (pralidoxime and blood pressure).
Stavinoha WB; Hinshaw LB; Smith PW; Rieger JA
Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):52-65. PubMed ID: 5480142
[No Abstract] [Full Text] [Related]
17. [Effect of obsidan on the systemic hemodynamics of dogs in ontogeny].
Brin VB
Farmakol Toksikol; 1977; 40(5):551-6. PubMed ID: 923777
[TBL] [Abstract][Full Text] [Related]
18. Vasodilative effect of hydralazine in awake dogs: the roles of prostaglandins and the sympathetic nervous system.
Maekawa K; Liang CS; Tsui A; Chen BT; Kawashima S
Circulation; 1984 Nov; 70(5):908-16. PubMed ID: 6488504
[TBL] [Abstract][Full Text] [Related]
19. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
Szekeres L; Udvary E; Papp JG
Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
[No Abstract] [Full Text] [Related]
20. Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action.
Côté P; Polumbo RA; Harrison DC
Cardiovasc Res; 1974 Nov; 8(6):721-30. PubMed ID: 4457225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
